{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:02:37Z","timestamp":1740135757371,"version":"3.37.3"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"crossref","award":["APQ-02112-10 and APQ 00793-13"],"award-info":[{"award-number":["APQ-02112-10 and APQ 00793-13"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2013\/24337-4","2018\/16511-8"],"award-info":[{"award-number":["2013\/24337-4","2018\/16511-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00380-019-01542-7","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T14:02:51Z","timestamp":1575900171000},"page":"719-730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mineralocorticoid receptor antagonists lead to increased adenosine bioavailability and modulate contractile cardiac parameters"],"prefix":"10.1007","volume":"35","author":[{"given":"Milla Marques","family":"Hermidorff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5209-0835","authenticated-orcid":false,"given":"Leonardo Vin\u00edcius Monteiro","family":"de Assis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel Alves","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le\u00f4ncio Lopes","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milton H\u00e9rcules Guerra","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f4nio Jos\u00e9","family":"Natali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro Cesar","family":"Isoldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"issue":"12","key":"1542_CR1","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/1440-1681.12156","volume":"40","author":"B Gravez","year":"2013","unstructured":"Gravez B, Tarjus A, Jaisser F (2013) Mineralocorticoid receptor and cardiac arrhythmia. Clin Exp Pharmacol Physiol 40(12):910\u2013915","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"14","key":"1542_CR2","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, Eplerenone Post-Acute Myocardial Infarction Heart Failure E, Survival Study I (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348(14):1309\u20131321","journal-title":"N Engl J Med"},{"issue":"10","key":"1542_CR3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341(10):709\u2013717","journal-title":"N Engl J Med"},{"issue":"3","key":"1542_CR4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00210-006-0107-9","volume":"374","author":"W Chai","year":"2006","unstructured":"Chai W, Danser AH (2006) Why are mineralocorticoid receptor antagonists cardioprotective? Naunyn Schmiedebergs Arch Pharmacol 374(3):153\u2013162","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"1542_CR5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10741-016-9591-2","volume":"22","author":"MM Hermidorff","year":"2017","unstructured":"Hermidorff MM, de Assis LV, Isoldi MC (2017) Genomic and rapid effects of aldosterone: what we know and do not know thus far. Heart Fail Rev 22(1):65\u201389","journal-title":"Heart Fail Rev"},{"issue":"1","key":"1542_CR6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijcard.2011.11.076","volume":"167","author":"F Beygui","year":"2013","unstructured":"Beygui F, Labbe JP, Cayla G, Ennezat PV, Motreff P, Roubille F, Silvain J, Barthelemy O, Delarche N, Van Belle E, Collet JP, Montalescot G (2013) Early mineralocorticoid receptor blockade in primary percutaneous coronary intervention for ST-elevation myocardial infarction is associated with a reduction of life-threatening ventricular arrhythmia. Int J Cardiol 167(1):73\u201379","journal-title":"Int J Cardiol"},{"issue":"4","key":"1542_CR7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.HYP.0000203148.42892.7a","volume":"47","author":"N Kobayashi","year":"2006","unstructured":"Kobayashi N, Yoshida K, Nakano S, Ohno T, Honda T, Tsubokou Y, Matsuoka H (2006) Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts. Hypertension 47(4):671\u2013679","journal-title":"Hypertension"},{"issue":"5","key":"1542_CR8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/10799893.2015.1122042","volume":"36","author":"CM Araujo","year":"2016","unstructured":"Araujo CM, Hermidorff MM, Amancio Gde C, Lemos Dda S, Silva ME, de Assis LV, Isoldi MC (2016) Rapid effects of aldosterone in primary cultures of cardiomyocytes - do they suggest the existence of a membrane-bound receptor? J Recept Signal Transduct Res 36(5):435\u2013444","journal-title":"J Recept Signal Transduct Res"},{"issue":"1","key":"1542_CR9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1139\/bcb-2014-0110","volume":"93","author":"MM Hermidorff","year":"2015","unstructured":"Hermidorff MM, Faria Gde O, Amancio Gde C, de Assis LV, Isoldi MC (2015) Non-genomic effects of spironolactone and eplerenone in cardiomyocytes of neonatal Wistar rats: do they evoke cardioprotective pathways? Biochem Cell Biol 93(1):83\u201393","journal-title":"Biochem Cell Biol"},{"issue":"8","key":"1542_CR10","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/bph.12902","volume":"172","author":"P Kleinbongard","year":"2015","unstructured":"Kleinbongard P, Heusch G (2015) Extracellular signalling molecules in the ischaemic\/reperfused heart - druggable and translatable for cardioprotection? Br J Pharmacol 172(8):2010\u20132025","journal-title":"Br J Pharmacol"},{"issue":"1\u20132","key":"1542_CR11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1007209321969","volume":"217","author":"N Safran","year":"2001","unstructured":"Safran N, Shneyvays V, Balas N, Jacobson KA, Nawrath H, Shainberg A (2001) Cardioprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes. Mol Cell Biochem 217(1\u20132):143\u2013152","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"1542_CR12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jcin.2014.02.009","volume":"7","author":"J Layland","year":"2014","unstructured":"Layland J, Carrick D, Lee M, Oldroyd K, Berry C (2014) Adenosine: physiology, pharmacology, and clinical applications. JACC Cardiovasc Interv 7(6):581\u2013591","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"1542_CR13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1074248410396877","volume":"17","author":"VJ McIntosh","year":"2012","unstructured":"McIntosh VJ, Lasley RD (2012) Adenosine receptor-mediated cardioprotection: are all 4 subtypes required or redundant? J Cardiovasc Pharmacol Ther 17(1):21\u201333","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"4","key":"1542_CR14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/FJC.0b013e3181f03d05","volume":"56","author":"VB Urmaliya","year":"2010","unstructured":"Urmaliya VB, Pouton CW, Ledent C, Short JL, White PJ (2010) Cooperative cardioprotection through adenosine A1 and A2A receptor agonism in ischemia-reperfused isolated mouse heart. J Cardiovasc Pharmacol 56(4):379\u2013388","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"1542_CR15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1139\/y99-023","volume":"77","author":"RD Lasley","year":"1999","unstructured":"Lasley RD, Randhawa MP Jr, Hegge JO, Mentzer RM (1999) Effects of adenosine and acadesine on interstitial nucleosides and myocardial stunning in the pig. Can J Physiol Pharmacol 77(4):259\u2013267","journal-title":"Can J Physiol Pharmacol"},{"issue":"6","key":"1542_CR16","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/0002-8703(92)90055-Z","volume":"124","author":"FT Bunch","year":"1992","unstructured":"Bunch FT, Thornton J, Cohen MV, Downey JM (1992) Adenosine is an endogenous protectant against stunning during repetitive ischemic episodes in the heart. Am Heart J 124(6):1440\u20131446","journal-title":"Am Heart J"},{"issue":"2","key":"1542_CR17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00005344-199902000-00016","volume":"33","author":"JB Louttit","year":"1999","unstructured":"Louttit JB, Hunt AA, Maxwell MP, Drew GM (1999) The time course of cardioprotection induced by GR79236, a selective adenosine A1-receptor agonist, in myocardial ischaemia-reperfusion injury in the pig. J Cardiovasc Pharmacol 33(2):285\u2013291","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"1542_CR18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/jmcc.2000.1282","volume":"33","author":"P Narayan","year":"2001","unstructured":"Narayan P, Mentzer RM Jr, Lasley RD (2001) Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes. J Mol Cell Cardiol 33(1):121\u2013129","journal-title":"J Mol Cell Cardiol"},{"issue":"13","key":"1542_CR19","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/eurheartj\/ehp555","volume":"31","author":"K Schmidt","year":"2010","unstructured":"Schmidt K, Tissier R, Ghaleh B, Drogies T, Felix SB, Krieg T (2010) Cardioprotective effects of mineralocorticoid receptor antagonists at reperfusion. Eur Heart J 31(13):1655\u20131662","journal-title":"Eur Heart J"},{"issue":"4","key":"1542_CR20","first-page":"356","volume":"28","author":"LM Pereira","year":"2002","unstructured":"Pereira LM, Querido DL, Madeira AC, Mandarim-De-Lacerda CA (2002) Volume-weighted mean glomerular volume in spontaneously hypertensive rats treated with different doses of spironolactone. Int Braz J Urol 28(4):356\u2013362","journal-title":"Int Braz J Urol"},{"issue":"1\u20132","key":"1542_CR21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0378-4347(97)00581-1","volume":"707","author":"MH Maguire","year":"1998","unstructured":"Maguire MH, Szabo I, Valko IE, Finley BE, Bennett TL (1998) Simultaneous measurement of adenosine and hypoxanthine in human umbilical cord plasma using reversed-phase high-performance liquid chromatography with photodiode-array detection and on-line validation of peak purity. J Chromatogr B Biomed Sci Appl 707(1\u20132):33\u201341","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"4","key":"1542_CR22","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1471-4159.1984.tb12832.x","volume":"43","author":"D Heymann","year":"1984","unstructured":"Heymann D, Reddington M, Kreutzberg GW (1984) Subcellular localization of 5'-nucleotidase in rat brain. J Neurochem 43(4):971\u2013978","journal-title":"J Neurochem"},{"issue":"2","key":"1542_CR23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0021-9258(18)66180-0","volume":"202","author":"HH Taussky","year":"1953","unstructured":"Taussky HH, Shorr E (1953) A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem 202(2):675\u2013685","journal-title":"J Biol Chem"},{"issue":"11","key":"1542_CR24","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1080\/08958370802632267","volume":"21","author":"GR Thome","year":"2009","unstructured":"Thome GR, Mazzanti CM, Ahmed M, Correa M, Spanevello RM, Maldonado PA, Luchese C, Cargnelutti D, Morsch VM, Duarte MM, Fiorenza AM, Nogueira CW, De Bona KS, Moretto MB, Da Luz SC, Mazzanti A, Schetinger MR (2009) Activity of ectonucleotidases and adenosine deaminase in rats exposed to cigarette smoke. Inhal Toxicol 21(11):906\u2013912","journal-title":"Inhal Toxicol"},{"key":"1542_CR25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1590\/S1806-37132004000600010","volume":"30","author":"MC Kaisemann","year":"2004","unstructured":"Kaisemann MC, Kritski AL, Pereira MdFC, Trajman A (2004) Pleural fluid adenosine deaminase detection for the diagnosis of pleural tuberculosis. J Bras Pneumol 30:549\u2013556","journal-title":"J Bras Pneumol"},{"key":"1542_CR26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.yjmcc.2015.12.012","volume":"90","author":"VN Lavorato","year":"2016","unstructured":"Lavorato VN, Del Carlo RJ, da Cunha DN, Okano BS, Belfort FG, de Freitas JS, da Mota GF, Quintao-Junior JF, Silame-Gomes LH, Drummond FR, Carneiro-Junior MA, de Oliveira EM, Monteiro BS, Primola-Gomes TN, Natali AJ (2016) Mesenchymal stem cell therapy associated with endurance exercise training: Effects on the structural and functional remodeling of infarcted rat hearts. J Mol Cell Cardiol 90:111\u2013119","journal-title":"J Mol Cell Cardiol"},{"issue":"9","key":"1542_CR27","doi-asserted-by":"crossref","first-page":"e73737","DOI":"10.1371\/journal.pone.0073737","volume":"8","author":"B Gravez","year":"2013","unstructured":"Gravez B, Tarjus A, Jimenez-Canino R, El Moghrabi S, Messaoudi S, Alvarez de la Rosa D, Jaisser F (2013) The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes. PLoS ONE 8(9):e73737","journal-title":"PLoS ONE"},{"issue":"10","key":"1542_CR28","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1074\/jbc.M113.519256","volume":"289","author":"D Lavall","year":"2014","unstructured":"Lavall D, Selzer C, Schuster P, Lenski M, Adam O, Schafers HJ, Bohm M, Laufs U (2014) The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation. J Biol Chem 289(10):6656\u20136668","journal-title":"J Biol Chem"},{"issue":"6","key":"1542_CR29","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/etc.504","volume":"30","author":"SA Raut","year":"2011","unstructured":"Raut SA, Howell WM, Angus RA (2011) Endocrine-disrupting effects of spironolactone in female western mosquitofish, Gambusia affinis. Environ Toxicol Chem 30(6):1376\u20131382","journal-title":"Environ Toxicol Chem"},{"issue":"6","key":"1542_CR30","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/jcmm.12064","volume":"17","author":"AM De Jong","year":"2013","unstructured":"De Jong AM, Maass AH, Oberdorf-Maass SU, De Boer RA, Van Gilst WH, Van Gelder IC (2013) Cyclical stretch induces structural changes in atrial myocytes. J Cell Mol Med 17(6):743\u2013753","journal-title":"J Cell Mol Med"},{"issue":"39","key":"1542_CR31","doi-asserted-by":"crossref","first-page":"29932","DOI":"10.1074\/jbc.M110.131342","volume":"285","author":"J Fagart","year":"2010","unstructured":"Fagart J, Hillisch A, Huyet J, Barfacker L, Fay M, Pleiss U, Pook E, Schafer S, Rafestin-Oblin ME, Kolkhof P (2010) A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule. J Biol Chem 285(39):29932\u201329940","journal-title":"J Biol Chem"},{"key":"1542_CR32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fphar.2016.00045","volume":"7","author":"B Braganca","year":"2016","unstructured":"Braganca B, Oliveira-Monteiro N, Ferreirinha F, Lima PA, Faria M, Fontes-Sousa AP, Correia-de-Sa P (2016) Ion fluxes through KCa2 (SK) and Cav1 (L-type) channels contribute to chronoselectivity of adenosine A1 receptor-mediated actions in spontaneously beating rat atria. Front Pharmacol 7:45","journal-title":"Front Pharmacol"},{"issue":"3","key":"1542_CR33","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.phrs.2011.11.013","volume":"65","author":"B Chanyshev","year":"2012","unstructured":"Chanyshev B, Shainberg A, Isak A, Litinsky A, Chepurko Y, Tosh DK, Phan K, Gao ZG, Hochhauser E, Jacobson KA (2012) Anti-ischemic effects of multivalent dendrimeric A(3) adenosine receptor agonists in cultured cardiomyocytes and in the isolated rat heart. Pharmacol Res 65(3):338\u2013346","journal-title":"Pharmacol Res"},{"issue":"3","key":"1542_CR34","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11302-015-9460-9","volume":"11","author":"MW Alnouri","year":"2015","unstructured":"Alnouri MW, Jepards S, Casari A, Schiedel AC, Hinz S, Muller CE (2015) Selectivity is species-dependent: characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors. Purinergic Signal 11(3):389\u2013407","journal-title":"Purinergic Signal"},{"issue":"3","key":"1542_CR35","doi-asserted-by":"crossref","first-page":"H421","DOI":"10.1152\/ajpheart.00262.2015","volume":"309","author":"AJ Natali","year":"2015","unstructured":"Natali AJ, Fowler ED, Calaghan SC, White E (2015) Voluntary exercise delays heart failure onset in rats with pulmonary artery hypertension. Am J Physiol Heart Circ Physiol 309(3):H421\u2013424","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9","key":"1542_CR36","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","volume":"2","author":"J Butler","year":"2017","unstructured":"Butler J, Anstrom KJ, Felker GM, Givertz MM, Kalogeropoulos AP, Konstam MA, Mann DL, Margulies KB, McNulty SE, Mentz RJ, Redfield MM, Tang WHW, Whellan DJ, Shah M, Desvigne-Nickens P, Hernandez AF, Braunwald E, National Heart L, Blood Institute Heart Failure Clinical Research N (2017) Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial. JAMA Cardiol 2(9):950\u2013958","journal-title":"JAMA Cardiol"},{"issue":"34","key":"1542_CR37","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/eurheartj\/ehu164","volume":"35","author":"G Montalescot","year":"2014","unstructured":"Montalescot G, Pitt B, Lopez de Sa E, Hamm CW, Flather M, Verheugt F, Shi H, Turgonyi E, Orri M, Vincent J, Zannad F, Investigators R, Investigators R (2014) Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the randomized double-blind reminder study. Eur Heart J 35(34):2295\u20132302","journal-title":"Eur Heart J"},{"issue":"11","key":"1542_CR38","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/eurjhf\/hfp136","volume":"11","author":"C Adamopoulos","year":"2009","unstructured":"Adamopoulos C, Ahmed A, Fay R, Angioi M, Filippatos G, Vincent J, Pitt B, Zannad F, Investigators E (2009) Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial. Eur J Heart Fail 11(11):1099\u20131105","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"1542_CR39","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1034\/j.1399-6576.2000.440903.x","volume":"44","author":"HT Sommerschild","year":"2000","unstructured":"Sommerschild HT, Kirkeboen KA (2000) Adenosine and cardioprotection during ischaemia and reperfusion\u2013an overview. Acta Anaesthesiol Scand 44(9):1038\u20131055","journal-title":"Acta Anaesthesiol Scand"},{"issue":"9\u201310","key":"1542_CR40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.lfs.2007.12.003","volume":"82","author":"B Rucker","year":"2008","unstructured":"Rucker B, Almeida ME, Libermann TA, Zerbini LF, Wink MR, Sarkis JJ (2008) E-NTPDases and ecto-5'-nucleotidase expression profile in rat heart left ventricle and the extracellular nucleotide hydrolysis by their nerve terminal endings. Life Sci 82(9\u201310):477\u2013486","journal-title":"Life Sci"},{"issue":"1","key":"1542_CR41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1096\/fj.03-0011fje","volume":"18","author":"T Hashikawa","year":"2004","unstructured":"Hashikawa T, Hooker SW, Maj JG, Knott-Craig CJ, Takedachi M, Murakami S, Thompson LF (2004) Regulation of adenosine receptor engagement by ecto-adenosine deaminase. FASEB J 18(1):131\u2013133","journal-title":"FASEB J"},{"issue":"3","key":"1542_CR42","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0306-4522(02)00058-1","volume":"113","author":"M Torvinen","year":"2002","unstructured":"Torvinen M, Gines S, Hillion J, Latini S, Canals M, Ciruela F, Bordoni F, Staines W, Pedata F, Agnati LF, Lluis C, Franco R, Ferre S, Fuxe K (2002) Interactions among adenosine deaminase, adenosine A(1) receptors and dopamine D(1) receptors in stably cotransfected fibroblast cells and neurons. Neuroscience 113(3):709\u2013719","journal-title":"Neuroscience"},{"issue":"4","key":"1542_CR43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrcardio.2016.5","volume":"13","author":"DJ Hausenloy","year":"2016","unstructured":"Hausenloy DJ, Yellon DM (2016) Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol 13(4):193\u2013209","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"1542_CR44","doi-asserted-by":"crossref","first-page":"e111248","DOI":"10.1371\/journal.pone.0111248","volume":"9","author":"TN van den Berg","year":"2014","unstructured":"van den Berg TN, Deinum J, Bilos A, Donders AR, Rongen GA, Riksen NP (2014) The effect of eplerenone on adenosine formation in humans in vivo: a double-blinded randomised controlled study. PLoS ONE 9(10):e111248","journal-title":"PLoS ONE"},{"issue":"4","key":"1542_CR45","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.HYP.0000182661.98259.4f","volume":"46","author":"W Chai","year":"2005","unstructured":"Chai W, Garrelds IM, de Vries R, Batenburg WW, van Kats JP, Danser AH (2005) Nongenomic effects of aldosterone in the human heart: interaction with angiotensin II. Hypertension 46(4):701\u2013706","journal-title":"Hypertension"},{"issue":"5","key":"1542_CR46","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/01.HYP.0000144466.11568.7e","volume":"44","author":"JC Barbato","year":"2004","unstructured":"Barbato JC, Rashid S, Mulrow PJ, Shapiro JI, Franco-Saenz R (2004) Mechanisms for aldosterone and spironolactone-induced positive inotropic actions in the rat heart. Hypertension 44(5):751\u2013757","journal-title":"Hypertension"},{"issue":"5","key":"1542_CR47","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.bjp.0706220","volume":"145","author":"W Chai","year":"2005","unstructured":"Chai W, Garrelds IM, Arulmani U, Schoemaker RG, Lamers JM, Danser AH (2005) Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective? Br J Pharmacol 145(5):664\u2013671","journal-title":"Br J Pharmacol"},{"issue":"8","key":"1542_CR48","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1210\/ME.2014-1410","volume":"29","author":"AW Ashton","year":"2015","unstructured":"Ashton AW, Le TY, Gomez-Sanchez CE, Morel-Kopp MC, McWhinney B, Hudson A, Mihailidou AS (2015) Role of nongenomic signaling pathways activated by aldosterone during cardiac reperfusion injury. Mol Endocrinol 29(8):1144\u20131155","journal-title":"Mol Endocrinol"},{"issue":"1","key":"1542_CR49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3317\/jraas.2006.005","volume":"7","author":"WC De Mello","year":"2006","unstructured":"De Mello WC (2006) Beneficial effect of eplerenone on cardiac remodelling and electrical properties of the failing heart. J Renin Angiotensin Aldosterone Syst 7(1):40\u201346","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"6","key":"1542_CR50","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.hrthm.2009.02.005","volume":"6","author":"BS Stambler","year":"2009","unstructured":"Stambler BS, Laurita KR, Shroff SC, Hoeker G, Martovitz NL (2009) Aldosterone blockade attenuates development of an electrophysiological substrate associated with ventricular tachyarrhythmias in heart failure. Heart Rhythm 6(6):776\u2013783","journal-title":"Heart Rhythm"},{"key":"1542_CR51","first-page":"1","volume":"6","author":"MM Hermidorff","year":"2015","unstructured":"Hermidorff MM, de Assis LVM, Isoldi MC (2015) Antagonists of the mineralocorticoid receptor or a new pharmacological class? Cell Sci Ther 6:1\u20132","journal-title":"Cell Sci Ther"},{"issue":"4","key":"1542_CR52","doi-asserted-by":"crossref","first-page":"H1875","DOI":"10.1152\/ajpheart.00158.2005","volume":"291","author":"RR Morrison","year":"2006","unstructured":"Morrison RR, Teng B, Oldenburg PJ, Katwa LC, Schnermann JB, Mustafa SJ (2006) Effects of targeted deletion of A1 adenosine receptors on postischemic cardiac function and expression of adenosine receptor subtypes. Am J Physiol Heart Circ Physiol 291(4):H1875\u20131882","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5 Pt 2","key":"1542_CR53","first-page":"H1460","volume":"263","author":"RD Lasley","year":"1992","unstructured":"Lasley RD, Mentzer RM Jr (1992) Adenosine improves recovery of postischemic myocardial function via an adenosine A1 receptor mechanism. Am J Physiol 263(5 Pt 2):H1460\u20131465","journal-title":"Am J Physiol"},{"issue":"4","key":"1542_CR54","doi-asserted-by":"crossref","first-page":"H1716","DOI":"10.1152\/ajpheart.00945.2007","volume":"294","author":"U Gergs","year":"2008","unstructured":"Gergs U, Boknik P, Schmitz W, Simm A, Silber RE, Neumann J (2008) A positive inotropic effect of ATP in the human cardiac atrium. Am J Physiol Heart Circ Physiol 294(4):H1716\u20131723","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"1542_CR55","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00210-018-1482-8","volume":"391","author":"JQD Rodrigues","year":"2018","unstructured":"Rodrigues JQD, Camara H, Jurkiewicz A, Godinho RO (2018) Increased Gi protein signaling potentiates the negative chronotropic effect of adenosine in the SHR right atrium. Naunyn Schmiedebergs Arch Pharmacol 391(5):513\u2013522","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"1542_CR56","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/PL00005010","volume":"355","author":"WR Ford","year":"1997","unstructured":"Ford WR, Broadley KJ (1997) Functional classification of P1-purinoceptors in guinea-pig left and right atria: anomalous characteristics of antagonism by cyclopentyltheophylline. Naunyn Schmiedebergs Arch Pharmacol 355(6):759\u2013766","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"1542_CR57","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF00168970","volume":"340","author":"H von der Leyen","year":"1989","unstructured":"von der Leyen H, Schmitz W, Scholz H, Scholz J, Lohse MJ, Schwabe U (1989) Effects of 1,3-dipropyl-8-cyclopentylxanthine (DPCPX), a highly selective adenosine receptor antagonist, on force of contraction in guinea-pig atrial and ventricular cardiac preparations. Naunyn Schmiedebergs Arch Pharmacol 340(2):204\u2013209","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"12","key":"1542_CR58","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.peptides.2008.09.003","volume":"29","author":"K Yuan","year":"2008","unstructured":"Yuan K, Bai GY, Park WH, Kim SZ, Kim SH (2008) Stimulation of ANP secretion by 2-Cl-IB-MECA through A(3) receptor and CaMKII. Peptides 29(12):2216\u20132224","journal-title":"Peptides"},{"issue":"4","key":"1542_CR59","doi-asserted-by":"crossref","first-page":"H1562","DOI":"10.1152\/ajpheart.00335.2002","volume":"283","author":"HR Cross","year":"2002","unstructured":"Cross HR, Murphy E, Black RG, Auchampach J, Steenbergen C (2002) Overexpression of A(3) adenosine receptors decreases heart rate, preserves energetics, and protects ischemic hearts. Am J Physiol Heart Circ Physiol 283(4):H1562\u20131568","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"1542_CR60","first-page":"175","volume":"6","author":"M Di Biase","year":"2005","unstructured":"Di Biase M, Troccoli R, Brunetti ND (2005) Non-antiarrhythmic drugs for the prevention of cardiac arrhythmias. Ital Heart J 6(3):175\u2013179","journal-title":"Ital Heart J"},{"key":"1542_CR61","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/164_2016_76","volume":"243","author":"P Kolkhof","year":"2017","unstructured":"Kolkhof P, Jaisser F, Kim SY, Filippatos G, Nowack C, Pitt B (2017) Steroidal and novel non-steroidal mineralocorticoid receptor antagonists in heart failure and cardiorenal diseases: comparison at bench and bedside. Handb Exp Pharmacol 243:271\u2013305","journal-title":"Handb Exp Pharmacol"},{"issue":"4","key":"1542_CR62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/clc.20324","volume":"31","author":"A Struthers","year":"2008","unstructured":"Struthers A, Krum H, Williams GH (2008) A comparison of the aldosterone-blocking agents eplerenone and spironolactone. Clin Cardiol 31(4):153\u2013158","journal-title":"Clin Cardiol"},{"issue":"6","key":"1542_CR63","doi-asserted-by":"crossref","first-page":"C532","DOI":"10.1152\/ajpcell.00203.2012","volume":"304","author":"R Gros","year":"2013","unstructured":"Gros R, Ding Q, Liu B, Chorazyczewski J, Feldman RD (2013) Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. Am J Physiol Cell Physiol 304(6):C532\u2013540","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"1542_CR64","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/HYPERTENSIONAHA.110.161653","volume":"57","author":"R Gros","year":"2011","unstructured":"Gros R, Ding Q, Sklar LA, Prossnitz EE, Arterburn JB, Chorazyczewski J, Feldman RD (2011) GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone. Hypertension 57(3):442\u2013451","journal-title":"Hypertension"},{"key":"1542_CR65","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-3-540-89615-9_7","volume":"193","author":"JP Headrick","year":"2009","unstructured":"Headrick JP, Lasley RD (2009) Adenosine receptors and reperfusion injury of the heart. Handb Exp Pharmacol 193:189\u2013214","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"1542_CR66","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0022-2828(92)91162-X","volume":"24","author":"RT Smolenski","year":"1992","unstructured":"Smolenski RT, Suitters A, Yacoub MH (1992) Adenine nucleotide catabolism and adenosine formation in isolated human cardiomyocytes. J Mol Cell Cardiol 24(1):91\u201396","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"1542_CR67","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1006\/jmcc.1997.0635","volume":"30","author":"RT Smolenski","year":"1998","unstructured":"Smolenski RT, Kalsi KK, Zych M, Kochan Z, Yacoub MH (1998) Adenine\/ribose supply increases adenosine production and protects ATP pool in adenosine kinase-inhibited cardiac cells. J Mol Cell Cardiol 30(3):673\u2013683","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"1542_CR68","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10557-013-6506-5","volume":"28","author":"RT Smolenski","year":"2014","unstructured":"Smolenski RT, Rybakowska I, Turyn J, Romaszko P, Zabielska M, Taegtmeyer A, Slominska EM, Kaletha KK, Barton PJ (2014) AMP deaminase 1 gene polymorphism and heart disease-a genetic association that highlights new treatment. Cardiovasc Drugs Ther 28(2):183\u2013189","journal-title":"Cardiovasc Drugs Ther"},{"issue":"3","key":"1542_CR69","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.CIR.85.3.893","volume":"85","author":"SW Ely","year":"1992","unstructured":"Ely SW, Berne RM (1992) Protective effects of adenosine in myocardial ischemia. Circulation 85(3):893\u2013904","journal-title":"Circulation"},{"issue":"2","key":"1542_CR70","doi-asserted-by":"crossref","first-page":"e006949","DOI":"10.1161\/JAHA.117.006949","volume":"7","author":"EY Shin","year":"2018","unstructured":"Shin EY, Wang L, Zemskova M, Deppen J, Xu K, Strobel F, Garcia AJ, Tirouvanziam R, Levit RD (2018) Adenosine Production by Biomaterial-Supported Mesenchymal Stromal Cells Reduces the Innate Inflammatory Response in Myocardial Ischemia\/Reperfusion Injury. J Am Heart Assoc 7(2):e006949","journal-title":"J Am Heart Assoc"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-019-01542-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-019-01542-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-019-01542-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:42:19Z","timestamp":1665189739000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-019-01542-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1542"],"URL":"https:\/\/doi.org\/10.1007\/s00380-019-01542-7","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"type":"print","value":"0910-8327"},{"type":"electronic","value":"1615-2573"}],"subject":[],"published":{"date-parts":[[2019,12,9]]},"assertion":[{"value":"11 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no conflict of interests that could have influence this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All national guidelines and requirements for animal use in research were rigorously met according to the Committee for Animal Use at the Federal University of Ouro Preto (Protocols No. 2011\/88 and 2016\/06). This article does not contain any studies with human participants performed by any of the authors. The data used to support the findings of this study are available from the corresponding author upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}